BiotechTube
Home/Avotres/Harvey L. Katzeff
HL

Harvey L. Katzeff

Chief Medical Officer (CMO)

Avotres

Therapeutic Areas

Autoimmune DiseasesTransplantationOncology

Avotres Pipeline

DrugIndicationPhase
AVT001Type 1 DiabetesPhase 2
AVT002Oncology (Melanoma model)Preclinical
AVT-Dx 001Autoimmune Disease DiagnosisDevelopment

Leadership Team at Avotres

HJ
Hong Jiang
Founder & Chief Scientific Officer (CSO)
AL
Alex Li
Chief Executive Officer (CEO)
YR
Yunling Ren
General Counsel
View full Avotres profile